What are Meningococcal conjugate vaccine drugs?

Meningococcal conjugate vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting Neisseria meningitidis serogroup C polysaccharide capsule). 6 are currently marketed, with 12 more in clinical development.

What are the marketed Meningococcal conjugate vaccine drugs?

Marketed Meningococcal conjugate vaccine drugs include MenACWY-TT, NeisVac-C®, MCV-A vaccine, NeisVac C vaccine (12mth), Menjugate®, MCV4.

Meningococcal conjugate vaccine

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

6 marketed 12 in Phase 3

This page covers all Meningococcal conjugate vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Neisseria meningitidis serogroup C polysaccharide capsule, Meningococcal serogroup A capsular polysaccharide, Meningococcal serogroup C polysaccharide capsule.

Targets

Neisseria meningitidis serogroup C polysaccharide capsule · Meningococcal serogroup A capsular polysaccharide · Meningococcal serogroup C polysaccharide capsule · Neisseria meningitidis serogroups A, C, W, Y polysaccharide capsules · Neisseria meningitidis serogroups B, C, W, Y polysaccharide antigens · Meningococcal polysaccharide capsule antigens

Marketed (6)

MenACWY-TT · Pfizer · Immunology / Infectious Disease
MenACWY-TT is a conjugate vaccine that stimulates the immune system to produce antibodies against meningococcal serogroups A, C, W, and Y by linking polysaccharide antigens to tetanus toxoid carrier protein.
NeisVac-C® · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
NeisVac-C is a meningococcal serogroup C conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C.
MCV-A vaccine · International Vaccine Institute · Immunology
MCV-A vaccine stimulates the immune system to produce antibodies and cellular immunity against meningococcal serogroup A polysaccharide capsule.
NeisVac C vaccine (12mth) · University of British Columbia · Immunology / Infectious Disease
NeisVac C is a conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C polysaccharide capsule.
Menjugate® · GlaxoSmithKline · Immunology / Infectious Disease
Menjugate is a meningococcal conjugate vaccine that stimulates the immune system to produce antibodies against serogroup C meningococcal polysaccharide capsule.
MCV4 · CanSino Biologics Inc. · Immunology / Infectious Disease
MCV4 is a meningococcal conjugate vaccine that stimulates the immune system to produce antibodies against serogroups A, C, W, and Y of Neisseria meningitidis.

Phase 3 pipeline (12)

MPV-ACYW135 Vaccine Group · Beijing Minhai Biotechnology Co., Ltd · Immunology
MPV-ACYW135 is a meningococcal polysaccharide conjugate vaccine that stimulates immune responses against serogroups A, C, Y, and W-135 of Neisseria meningitidis.
MSPV4 · CanSino Biologics Inc. · Immunology / Infectious Disease
MSPV4 is a recombinant meningococcal serogroup B, C, W, and Y conjugate vaccine that stimulates immune responses against multiple meningococcal serogroups.
Menactra TM · GlaxoSmithKline · Immunology / Infectious Disease
Menactra is a meningococcal conjugate vaccine that stimulates the immune system to produce antibodies against serogroups A, C, W, and Y of Neisseria meningitidis.
Mencevax™ACWY · GlaxoSmithKline · Immunology / Infectious Disease
Mencevax ACWY is a meningococcal conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroups A, C, W, and Y.
MPSV4 · CanSino Biologics Inc. · Immunology / Infectious Disease
MPSV4 is a meningococcal polysaccharide conjugate vaccine that stimulates immune responses against multiple serogroups of Neisseria meningitidis.
NeisVac-CTM · GlaxoSmithKline · Immunology / Infectious Disease
NeisVac-C is a meningococcal C conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C.
MenACWY-CRM197 · Novartis · Immunology / Infectious Disease
MenACWY-CRM197 is a meningococcal conjugate vaccine that stimulates immune responses against serogroups A, C, W, and Y by conjugating polysaccharide antigens to a carrier protein (CRM197).
MencevaxACWY TM · GlaxoSmithKline · Immunology
MencevaxACWY is a meningococcal conjugate vaccine that stimulates the immune system to produce antibodies against serogroups A, C, W, and Y of Neisseria meningitidis.
Meningococcal conjugate vaccine GSK134612 · GlaxoSmithKline · Immunology / Infectious Disease
This conjugate vaccine stimulates the immune system to produce antibodies against meningococcal polysaccharide capsules by linking them to a protein carrier.
MenitorixTM · GlaxoSmithKline · Immunology / Infectious Disease
Meningococcal conjugate vaccine that stimulates immune response against Neisseria meningitidis serogroups A, C, W, and Y.
Mencevax™ ACW · GlaxoSmithKline · Immunology / Infectious Disease
Mencevax ACW is a meningococcal polysaccharide conjugate vaccine that stimulates immune response against Neisseria meningitidis serogroups A, C, W, and Y.
MCV-ACYW135 Vaccine Group · Beijing Minhai Biotechnology Co., Ltd · Immunology
MCV-ACYW135 is a meningococcal conjugate vaccine that stimulates immune response against serogroups A, C, Y, and W-135 of Neisseria meningitidis.

Patent intelligence

meningococcal conjugate vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates